MARKET

BMRN

BMRN

BioMarin Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

75.33
-0.57
-0.75%
After Hours: 75.33 0 0.00% 17:26 11/11 EST
OPEN
75.38
PREV CLOSE
75.90
HIGH
76.42
LOW
74.90
VOLUME
1.44M
TURNOVER
--
52 WEEK HIGH
100.13
52 WEEK LOW
62.88
MARKET CAP
13.53B
P/E (TTM)
-300.8387
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of BMRN and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 24 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

BMRN News

  • 2 Beaten-Down Biotech Stocks That Could Make You Rich
  • MotleyFool.com.8h ago
  • Sarepta (SRPT) Q3 Loss Widens Y/Y, Revenues Beat Estimates
  • Zacks.3d ago
  • After son’s rare disease diagnosis, father finds hope through film festival
  • American City Business Journals.3d ago
  • BioMarin to Highlight Innovative Development Pipeline at R&D Day on November 14th
  • PR Newswire.5d ago

More

Industry

Pharmaceuticals
-0.41%
Pharmaceuticals & Medical Research
-0.43%

Hot Stocks

Name
Price
%Change

About BMRN

BioMarin Pharmaceutical Inc. is a biotechnology company. The Company develops and commercializes pharmaceuticals for various diseases and medical conditions. As of December 31, 2016, the Company's therapy portfolio consisted of five products, and multiple clinical and pre-clinical product candidates. Its commercial products include Aldurazyme (laronidase) for Mucopolysaccharidosis I (MPS I), Firdapse (amifampridine phosphate) for Lambert Eaton Myasthenic Syndrome (LEMS), Kuvan (sapropterin dihydrochloride) for phenylketonuria (PKU), Naglazyme (galsulfase) for Mucopolysaccharidosis VI (MPS VI) and Vimizim (elosulfase alpha) for Mucopolysaccharidosis IV Type A (MPS IV A). The Company is conducting clinical trials on various product candidates for the treatment of various diseases. Its clinical product candidates include Brineura, pegvaliase, vosoritide, BMN 270 and BMN 250.
More

Webull offers BioMarin Pharmaceutical Inc. (BMRN) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.